M Yiagnisis
About
In The Last Decade
M Yiagnisis
18 papers receiving 441 citations
Peers
Comparison fields: 5 of 54
- Oncology 312
- Molecular Biology 178
- Otorhinolaryngology 128
- Surgery 89
- Cancer Research 76
Countries citing papers authored by M Yiagnisis
This map shows the geographic impact of M Yiagnisis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Yiagnisis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Yiagnisis more than expected).
Fields of papers citing papers by M Yiagnisis
This network shows the impact of papers produced by M Yiagnisis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Yiagnisis. The network helps show where M Yiagnisis may publish in the future.
Co-authorship network of co-authors of M Yiagnisis
This figure shows the co-authorship network connecting the top 25 collaborators of M Yiagnisis. A scholar is included among the top collaborators of M Yiagnisis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Yiagnisis. M Yiagnisis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | First report of Vibrio anguillarum isolation from diseased big scale sand smelt, Atherina boyeri Risso 1810, in Limnos, Greece | 9 |
| 2 | Ceratomyxa spp. (Myxosporea) infection in cultured shi drum (Umbrina cirrosa) and cultured brown meagre (Sciaena umbra) from Greece | 4 |
| 3 | 6 | |
| 4 | Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease. | 6 |
| 5 | C-erbB-2 expression in squamous cell carcinoma of the head and neck. | 62 |
| 6 | Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma. | 17 |
| 7 | Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma. | 13 |
| 8 | 5 | |
| 9 | 227 | |
| 10 | ras, c-myc and c-erbB-2 oncoproteins in human breast cancer. | 29 |
| 11 | Evaluation of the ras and myc oncoproteins in benign gastric lesions. | 4 |
| 12 | Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours. | 7 |
| 13 | Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa. | 10 |
| 14 | Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung. | 9 |
| 15 | Human immunodeficiency virus long terminal repeat responds to transformation by the mutant T24 H-ras1 oncogene and it contains multiple AP-1 binding TPA-inducible consensus sequence elements. | 16 |
| 16 | Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms. | 10 |
| 17 | Interleukin 3 like activity secreted from human ras or myc transfected rodent cells. | 7 |
| 18 | Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.